According to London-based think tank Airfinity, representatives from the United States, the United Kingdom, Japan, and the European Union have agreed to supply more than 1.3 billion doses of potential coronavirus vaccines. Bloomberg reports.
Analytics fear that richer countries will monopolize vaccine supplies. We are talking about the United States and Britain, whose representatives have signed agreements on the supply of vaccines from Sanofi and GlaxoSmithKline Plc. Japan also entered into a similar agreement with Pfizer.
Despite this, it is not known whether the vaccines will prove to be effective.
It is noted that the total number of supply contracts could grow by 1.5 billion. There is concern that poorer countries will have to wait long “inline” to receive their supply.
International organizations and a number of countries promise that vaccines will be available to everyone, but it is impossible to provide them to the entire population of the earth, said Rasmus Beh Hansen, CEO of Airfinity.
At the moment, the companies with which the supply contracts were concluded are at the final stage of testing. However, the effectiveness of the drugs they are developing has yet to prove to be true.
Note that in Russia, according to the head of the Ministry of Health Mikhail Murashko, mass vaccination should begin in October this year. He clarified that the Russians will be injected with a vaccine that was developed at the Gamaleya National Research Center for Epidemiology and Microbiology, the clinical trials of which have already been completed. The drug has proven to be safe and effective, the minister added.